These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17532415)

  • 21. Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
    Dhaun N; MacIntyre IM; Kerr D; Melville V; Johnston NR; Haughie S; Goddard J; Webb DJ
    Hypertension; 2011 Apr; 57(4):772-9. PubMed ID: 21357275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equine pulmonary and systemic haemodynamic responses to endothelin-1 and a selective ET(A) receptor antagonist.
    Benamou AE; Marlin DJ; Lekeux P
    Equine Vet J; 2001 Jul; 33(4):337-44. PubMed ID: 11469765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a paf-receptor antagonist on hemodynamics during and after cardiopulmonary bypass.
    Nathan N; Mercury P; Denizot Y; Cornu E; Laskar M; Lathelize M; Arnoux B; Feiss P
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):647-52. PubMed ID: 8664454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiopulmonary bypass is associated with altered vascular reactivity of isolated pulmonary artery in a porcine model: therapeutic potential of inhaled tezosentan.
    Mommerot A; Denault AY; Dupuis J; Carrier M; Perrault LP
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):698-708. PubMed ID: 24917060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged anti-hypertensive effects of oral sitaxsentan, a selective ET(A) endothelin receptor antagonist, in spontaneoulsy hypertensive hamsters.
    Rubinstein I
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):387-90. PubMed ID: 17043751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials.
    Langleben D; Brock T; Dixon R; Barst R;
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S80-4. PubMed ID: 15838366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of angiotensin-I-converting-enzyme insertion/deletion gene polymorphism on perioperative hemodynamics after coronary bypass graft surgery.
    Popov AF; Hinz J; Liakopoulos OJ; Schmitto JD; Seipelt R; Quintel M; Schoendube FA
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):255-60. PubMed ID: 18431347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary hemodynamic and respiratory indices in low-risk coronary artery bypass patients.
    Santini F; Onorati F; Telesca M; Patelli F; Berton G; Franchi G; Faggian G; Mazzucco A
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):794-803. PubMed ID: 21388821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of eNOS gene polymorphisms (894G/T; - 786C/T) on postoperative hemodynamics after cardiac surgery.
    Liakopoulos OJ; Dörge H; Popov AF; Schmitto JD; Cattaruzza M; Schoendube FA
    Thorac Cardiovasc Surg; 2006 Jun; 54(4):233-8. PubMed ID: 16755443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin.
    Toikkanen V; Rinne T; Laurikka J; Porkkala H; Tarkka M; Mennander A
    Scand J Clin Lab Invest; 2017 Sep; 77(5):315-320. PubMed ID: 28460544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest.
    Kirshbom PM; Tsui SS; DiBernardo LR; Meliones JN; Schwinn DA; Ungerleider RM; Gaynor JW
    Surgery; 1995 Aug; 118(2):440-4; discussion 444-5. PubMed ID: 7638762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow.
    Petrossian E; Parry AJ; Reddy VM; Akkersdijk GP; McMullan DM; Thompson L; Hendricks-Munoz KD; Hallak H; Hanley FL; Fineman JR
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):314-23. PubMed ID: 9918974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-operative effects of olprinone after coronary artery bypass grafting.
    Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Kimura S; Ohmiya S; Sezai A; Yamada H; Obana M; Sezai Y
    Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):340-6. PubMed ID: 9914463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension.
    Rondelet B; Kerbaul F; Vivian GF; Hubloue I; Huez S; Fesler P; Remmelink M; Brimiouille S; Salmon I; Naeije R
    Pediatr Res; 2007 Mar; 61(3):284-8. PubMed ID: 17314684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
    Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical relevance of hemoglobin, platelet, and serotonin changes in sequestered and circulating blood during cardiopulmonary bypass.
    McNulty SE; Mannion J; Brennan M; Schieren H
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):402-7. PubMed ID: 9713727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective and mixed endothelin receptor antagonism in cardiovascular disease.
    Dhaun N; Pollock DM; Goddard J; Webb DJ
    Trends Pharmacol Sci; 2007 Nov; 28(11):573-9. PubMed ID: 17950470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass.
    Rahman A; Aydin S; Bayar MK; Sahin I
    J Physiol Biochem; 2008 Sep; 64(3):221-30. PubMed ID: 19244936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.